Status:

COMPLETED

Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis

Lead Sponsor:

Rennes University Hospital

Conditions:

Sarcoidosis

Eligibility:

All Genders

Brief Summary

Evaluation of the rate of achievement of serum protein electrophoresis (PPE) in diagnosis in a retrospective cohort of patients at Rennes University Hospital

Detailed Description

In 50% of cases, sarcoidosis is associated with polyclonal hypergammaglobulinemia. The other forms have a normal gamma globulin level. The level of gamma globulinemia has not yet been studied as an e...

Eligibility Criteria

Inclusion

  • \- Patients newly diagnosed with sarcoidosis

Exclusion

  • Comorbidity responsible for a change in the level of gamma globulin
  • Other etiology of granulomatosis

Key Trial Info

Start Date :

March 7 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 22 2017

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT03259282

Start Date

March 7 2017

End Date

March 22 2017

Last Update

April 12 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Rennes

Rennes, France, 35033

Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis | DecenTrialz